Skip to main content
Category

Lab

Chronic Kidney DiseaseKidney DiseaseLabMedia ReleasesMolecular Endocrinology and PharmacologyNews & EventsResearchResearch Area

Phase 3 drug trial for rare chronic kidney disease achieves key milestone

By | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research Area

Biopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…

Cardiovascular DiseaseCardiovascular DiseaseCardiovascular Science and Diabetes ProgramDiabetesFundingNews & EventsResearch

Federal government supports new treatment to clear blocked arteries

By | Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Diabetes, Funding, News & Events, Research

A Western Australian medical research team developing a new treatment for cardiovascular disease has received $2,147,254 in Federal government funding to develop a first-ever drug to clear blocked arteries. The…

CancerCancerFundingMelanomaMelanoma DiscoveryMelonomaNews & EventsPersonalized MedicineResearch

$3.5 million research collaborative brings cell therapy for solid cancers to WA

By | Cancer, Cancer, Funding, Melanoma, Melanoma Discovery, Melonoma, News & Events, Personalized Medicine, Research

Researchers from the Western Australia Melanoma Initiative (WAMI), a cancer research collaborative, will implement a specialised immune cell therapy for cancer patients in WA, thanks to a $2.5 million grant…